SCHEMBL7651570

SCHEMBL7651570

O=C(C(=O)N1CCN(C(=O)c2ccccc2)CC1)c1c[nH]c2cccc(Cl)c12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.52
CYP2C19 P33261 3/20 0.50
CYP2D6 P10635 2/20 0.50
MAPT P10636 1/20 0.50
RAB9A P51151 1/20 0.48
POLB P06746 1/20 0.48
NR4A2 P43354 1/20 0.47
LMNA P02545 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP3A4 P08684 2/20 0.46
ABL1 P00519 1/20 0.45
BCR P11274 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C8 P10632 1/20 0.45
CYP2B6 P20813 1/20 0.45
KCNH2 Q12809 1/20 0.45
HTT P42858 1/20 0.44
MAPK14 Q16539 1/20 0.44
GFER P55789 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4247829 0.86 CYP2C9 (0.52) CYP2C9CYP2C19CYP2D6MAPTRAB9A
SCHEMBL3843612 0.82 POLB (0.71) CYP2C9CYP2C19CYP2D6MAPTRAB9A
SCHEMBL7652677 0.77 CYP2C9 (0.50) CYP2C9CYP2C19CYP2D6MAPTRAB9A
SCHEMBL9942658 0.77 CYP2C9 (0.60) CYP2C9CYP2C19CYP2D6RAB9ALMNA
SCHEMBL2629011 0.76 CYP2C9 (0.59) CYP2C9CYP2C19CYP2D6LMNAALDH1A1
SCHEMBL12523198 0.76 CYP2C9 (0.61) CYP2C9CYP2C19CYP2D6LMNAALDH1A1
SCHEMBL2629012 0.76 CYP2C9 (0.59) CYP2C9CYP2C19CYP2D6RAB9ALMNA
SCHEMBL2629013 0.76 CYP2C9 (0.58) CYP2C9CYP2C19CYP2D6RAB9ALMNA
SCHEMBL19286011 0.75 CYP2C9 (0.60) CYP2C9CYP2C19CYP2D6RAB9APOLB
SCHEMBL12151872 0.75 POLB (0.46) CYP2C9CYP2C19CYP2D6MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6469006-B1 PARTICULARLY FOR TREATING HIV INFECTIONS BRISTOL-MYERS SQUIBB COMPANY 2002-10-22 US disclosed
EP-1105135-A4 ANTIVIRAL INDOLEOXOACETYL PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2001-12-12 EP disclosed
EP-1105135-A1 ANTIVIRAL INDOLEOXOACETYL PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2001-06-13 EP disclosed
WO-2000076521-A1 ANTIVIRAL INDOLEOXOACETYL PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2000-12-21 WO disclosed